Cite
HARVARD Citation
Kakizaki, Y. et al. (n.d.). Evaluation of the CGMs in type-2 diabetic patients switched from Liraglutide and Insulin Degludec to Liraglutide and Insulin Degludec/Aspart. Diabetes research and clinical practice. pp. S111-. [Online].